Huh. They’re guiding for 15% per annum profit growth for the next five years. (Independent of new drug approvals)
- Forums
- ASX - By Stock
- Ann: Top-line Results from the Phase 3 AEGIS-II Trial
CSL
csl limited
Add to My Watchlist
3.35%
!
$256.72

Huh. They’re guiding for 15% per annum profit growth for the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$256.72 |
Change
8.330(3.35%) |
Mkt cap ! $124.1B |
Open | High | Low | Value | Volume |
$252.00 | $256.75 | $251.10 | $249.1M | 967.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 126 | $256.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$256.72 | 51 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 37 | 256.260 |
2 | 8 | 256.250 |
3 | 113 | 256.240 |
3 | 16 | 256.230 |
3 | 31 | 256.220 |
Price($) | Vol. | No. |
---|---|---|
256.270 | 7 | 2 |
256.310 | 34 | 5 |
256.320 | 7 | 2 |
256.330 | 5 | 1 |
256.340 | 34 | 2 |
Last trade - 14.04pm 18/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |